News Sentiment

OMCL sentiment intelligence

Omnicell Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 45 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 44.92 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+4.4% over one week, +18.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

[144] OMNICELL, INC. SEC Filing

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction 4.4% Price confirming higher
Trend fit Trend inactive 18.7% over four weeks
Fair value 19.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 17
Neutral 27
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
TradingView 6
simplywall.st 6
Stock Titan 4
Simply Wall Street 3
StockStory 3
The Globe and Mail 1
Moomoo 1

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 10
Analyst action 3
Macro sensitivity 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 45
Stock Titan Direct company coverage

[144] OMNICELL, INC. SEC Filing

This article details an SEC Form 144 filing by Omnicell, Inc. concerning the proposed sale of 10,000 shares of common stock with an aggregate market value of $470,000. The shares were acquired by "Common Merrill Lynch" on January 16, 2021, through equity compensation. The filing

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 19:41
Source
Stock Titan
Simply Wall Street Direct company coverage

Does Omnicell’s ESOP Share Registration and Leadership Shift Reframe Its Capital Allocation Story (OMCL)?

Omnicell (OMCL) recently filed a US$72.384 million shelf registration for 1.6 million common shares tied to its ESOP and promoted Nnamdi Njoku to President, signaling potential shifts in capital allocation and operational direction. While the core investment narrative remains foc

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 20:41
Source
Simply Wall Street
Moomoo Direct company coverage

Press Release: Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026

Omnicell (NASDAQ: OMCL) announced it will release its second quarter 2026 financial results on Thursday, July 30, 2026, after the market closes. The company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss these results. Interested parties c

Tone
Neutral 50/100
Event
Earnings
Published
14 Jul 2026 08:14
Source
Moomoo
BioSpace Direct company coverage

Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026

Omnicell, Inc. (Nasdaq: OMCL) announced it will release its second quarter 2026 financial results before market open on Thursday, July 30, 2026. The company will host a conference call and webcast to discuss these results at 8:30 a.m. ET on the same day. Interested parties can ac

Tone
Neutral 50/100
Event
Earnings
Published
14 Jul 2026 03:12
Source
BioSpace
TradingView Direct company coverage

OMCL6251486 Bond Risk Profile

This page provides a risk profile for the Omnicell, Inc. OMCL6251486 bond, detailing its coupon and redemption risks. It highlights key metrics for credit risk assessment, including security level and issuer rating. The platform also offers access to exclusive analyst ratings for

Tone
Neutral 50/100
Event
Analyst action
Published
14 Jul 2026 02:12
Source
TradingView
TradingView Direct company coverage

OMCL6251486 Bond Profile — Key Metrics

This article provides key metrics for the Omnicell, Inc. 1.0% 01-DEC-2029 bond, identified as OMCL6251486 FINRA. It details the issuer, issue and maturity dates, outstanding amount, face value, minimum denomination, and coupon rate. Omnicell, Inc. is described as a provider of me

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 01:12
Source
TradingView
scanx.trade Direct company coverage

Omnicell to release Q2 2026 financial results on July 30

Omnicell, Inc. announced it will release its second quarter 2026 financial results before the market opens on Thursday, July 30, 2026. The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss its performance. Details for joining the conferenc

Tone
Neutral 50/100
Event
Earnings
Published
13 Jul 2026 22:12
Source
scanx.trade
Stock Titan Direct company coverage

Earnings day ahead: Omnicell to unveil Q2 2026 results on July 30

Omnicell, Inc. (Nasdaq: OMCL) is scheduled to release its financial results for the second quarter of 2026 before the market opens on Thursday, July 30, 2026. The company will also host a conference call and webcast on the same day at 8:30 a.m. ET to discuss these results. Intere

Tone
Neutral 50/100
Event
Earnings
Published
13 Jul 2026 20:01
Source
Stock Titan
Investing.com Direct company coverage

KeyBanc reiterates Omnicell stock rating on Titan XT launch

KeyBanc has reiterated an Overweight rating and a $70.00 price target for Omnicell (NASDAQ:OMCL) following the launch of its Titan XT Cabinets. The new enterprise platform is designed to enhance data collection and streamline pharmacy tasks for healthcare systems. Omnicell has sh

Tone
Positive 70/100
Event
Analyst action
Published
13 Jul 2026 12:10
Source
Investing.com
Simply Wall Street Direct company coverage

Omnicell (OMCL) Could Be 26% Below Fair Value Following Leadership And Index Changes

Omnicell (OMCL) is under increased scrutiny due to the appointment of a new president and its inclusion in Russell 2000 Defensive and Value-Defensive Indexes. Despite recent stock gains, a Simply Wall St analysis suggests the company is 26.4% undervalued, with a fair value of $61

Tone
Positive 66/100
Event
Market update
Published
10 Jul 2026 07:09
Source
Simply Wall Street
TradingView Direct company coverage

Should You Continue to Hold OMCL Stock in Your Portfolio Now?

Omnicell (OMCL) is expected to grow, driven by its advancements in autonomous pharmacy and expansion of SaaS and Expert Services. Despite positive earnings surprises and stock performance, the company faces headwinds from macroeconomic factors, competitive pressure, and escalatin

Tone
Positive 65/100
Event
Earnings
Published
09 Jul 2026 18:40
Source
TradingView
Dallas Innovates Direct company coverage

Fort Worth’s Omnicell Names Chief Operating Officer as President

Omnicell Inc., a Fort Worth-based healthcare tech company, has appointed Nnamdi Njoku as its new President, in addition to his current role as Chief Operating Officer. Njoku will be responsible for leading Omnicell’s long-term growth and innovation strategies, including scaling g

Tone
Positive 70/100
Event
Market update
Published
09 Jul 2026 12:40
Source
Dallas Innovates
TradingView Direct company coverage

Enterprise value to revenue forward of Omnicell, Inc. – DUS:OC9

The article provides the "Enterprise value to revenue forward" metric for Omnicell, Inc. (DUS:OC9) on the Dusseldorf Stock Exchange. It indicates the latest value and any changes, noting that the market is currently closed with no trades. The content primarily shows the financial

Tone
Neutral 50/100
Event
Earnings
Published
08 Jul 2026 08:40
Source
TradingView
Simply Wall Street Direct company coverage

Does Omnicell's (OMCL) Leadership Shift and Index Move Reframe Its Healthcare Automation Narrative?

Omnicell recently appointed Nnamdi Njoku as President and COO, while founder Randall Lipps will focus on long-term strategy and collaborations. Concurrently, Omnicell was added to the Russell 2000 Defensive and Russell 2000 Value-Defensive Indexes, increasing its visibility to de

Tone
Positive 60/100
Event
Market update
Published
07 Jul 2026 18:40
Source
Simply Wall Street
TradingView Direct company coverage

What's Fueling Omnicell Stock's 52.6% Rally Over the Past Year?

Omnicell (OMCL) shares have surged 52.6% over the past year, significantly outperforming its industry and the S&P 500, driven by its vision of autonomous pharmacy solutions. The company's growth is fueled by increasing SaaS and Expert Services revenues, growing adoption within he

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 14:13
Source
TradingView
AlphaStreet Direct company coverage

Omnicell Jumps 7.8% Amid Sector-Wide Rally

Omnicell (NASDAQ: OMCL) saw its stock rise by 7.8% to $46.37 on Monday, July 6, 2026, as part of a broader sector rally that also boosted several of its health information services peers. The synchronized gains, which included BFLY surging 13.7% and CHRN climbing 13.1%, indicate

Tone
Positive 71/100
Event
Market update
Published
07 Jul 2026 07:09
Source
AlphaStreet
Finviz Direct company coverage

OMCL - Omnicell Inc Options

The article provides a detailed financial overview of Omnicell Inc. (OMCL), including its stock performance, key financial ratios, insider transactions, and analyst recommendations. It highlights the company's market capitalization, income, sales, and various profitability and ef

Tone
Negative 41/100
Event
Analyst action
Published
06 Jul 2026 21:13
Source
Finviz
Stock Titan Direct company coverage

Omnicell (NASDAQ: OMCL) President & COO awarded 12,309 RSUs in promotion grant

Omnicell's President & COO, Nnamdi Njoku, was awarded 12,309 Restricted Stock Units (RSUs) as part of a promotion grant effective July 1, 2026. These RSUs will vest over three years, with one-third vesting on the first anniversary and the remainder in equal installments on the se

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 20:10
Source
Stock Titan
Investing.com Canada Direct company coverage

Form 4 Omnicell Inc For: 6 July By Investing.com

This article reports on a Form 4 filing for Omnicell Inc. on July 6th, published by Investing.com. It mentions that Omnicell Inc. (OMCL) saw a 5.14% increase and includes a general disclaimer about the risks of trading financial instruments. Beyond the title and stock ticker, the

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 20:10
Source
Investing.com Canada
TradingView Direct company coverage

Enterprise value to EBIT forward of Omnicell, Inc. – NASDAQ:OMCL

This article focuses on the enterprise value to EBIT forward for Omnicell, Inc. (NASDAQ: OMCL). It provides a brief financial overview of the company within the TradingView platform, indicating market closure and no recent trades. The content primarily serves as a placeholder or

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 14:10
Source
TradingView
Sahm Direct company coverage

Is Omnicell (OMCL) A Bargain Following Its New President Appointment?

Omnicell (OMCL) is gaining investor attention after appointing Nnamdi Njoku as President, sparking interest in its long-term strategy. The stock price of $41.93 suggests it might be undervalued, with a narrative fair value of $61.29 driven by strong demand for its medication mana

Tone
Positive 67/100
Event
Macro sensitivity
Published
02 Jul 2026 18:10
Source
Sahm